Dr. Stacy D’Andre is a board-certified internal medicine specialist and oncologist
with expertise in treating elderly patients with gastrointestinal (GI) and gynecologic
cancers. In addition to patient care, Dr. D’Andre leads treatment advances through
her research into new therapies and optimal management of colorectal, pancreatic,
endometrial and other types of cancer. She is a Principal Investigator for National
Cancer Institute-sponsored oncology group clinical trials including GOG (Gynecologic
Oncology Group) and NSABP (National Surgical Adjuvant Breast and Bowel Project), as
well as for industry-sponsored clinical trials supported by the Sutter Institute for
Medical Research (SIMR). Dr. D’Andre serves as Executive Chair of the Sutter
Cancer Research Consortium as well as Medical Director at Sutter Cancer Center. She
has authored numerous publications, book chapters and abstracts on emerging treatment
options for gynecologic and GI cancers.
Sutter Institute for Medical Research
2800 L Street, Suite 300
Sacramento, CA, 95816
(916) 453-3300
simr@sutterhealth.org
Primary Research Interests
- Biliary Cancer
- Brain Cancer
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Cancer
- Gastrointestinal Cancer
- Head and Neck Cancer
- Hemotologic Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Molecular/Rare Tumor
- Oncology Diets
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Rare Cancers
- Renal Cancer
- Sarcoma
- Skin Cancer/Melanoma
- Solid Tumors
- Urinary Tract Cancer
Related Clinical Trials
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (CheckMate 498)
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide.
Investigator: Stacy D'Andre MD
An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) (CheckMate548)
A Randomized Phase 3 Single Blind Study of Temozolomide Plus Radiation Therapy Combined
With Nivolumab or Placebo.
Investigator: Stacy D'Andre MD
Metastatic (Idera Melanoma)
A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects
With Anti-PD-1 Refractory Melanoma
Investigators: Deepti Behl MD, Stacy D'Andre MD, Nitin Rohatgi MD, Melissa Williams M.D.
Metastatic (Novocure LUNAR)
Effect of Tumor Treating Fields Concurrent W/ Standard of Care Therapies for Treatment
of Stage 4 NSCLC following Platinum Failure (LUNAR)
Investigators: Deepti Behl MD, Stacy D'Andre MD, Nitin Rohatgi MD, Melissa Williams M.D.
Status: Active, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
To learn real world practice of prescribing targeted therapies to patients with advanced
cancers.
Investigator: Stacy D'Andre MD
Publications
5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study.
5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients:
a north central cancer treatment group study.
Oxalate transport in cultured porcine renal epithelial cells.
Oxalate transport in cultured porcine renal epithelial cells.